The Prelieve Trial - Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Heart Failure Patients
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 106 participants.
Also called NCT03030274
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 106 participants
- Sponsor
- Registry
-
NCT03030274
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Belgium, Germany, Türkiye
- Registry status
- Completed
Technical summary
Registry record NCT03030274. Allocation not applicable; no masking; primary purpose treatment. Start 2017-10-11 (actual); primary completion 2021-05-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Prelieve Trial - Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Heart Failure Patients
- Acronym
- PRELIEVE
- Condition
- Heart Failure Low Output
- Condition
- Heart Failure
- Intervention (Device)
- Occlutech AFR device
- Lead sponsor
- Occlutech International AB
Record details
- Record id
cardio:ct-nct03030274- Content hash
28b197e9ce68b9ca9b067a6d6f8a88b64e7c5a764093dab257681d95bc86a607